Alex Gonzalez Selected Research

Interleukin 1 Receptor Antagonist Protein (Anakinra)

10/2021	Targeting interleukin-1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis.
1/2021	The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex Gonzalez Research Topics

Disease

7	Cachexia 10/2022 - 01/2020
4	Infantile Nephropathic Cystinosis 10/2022 - 01/2020
4	Insulin Resistance 01/2022 - 07/2015
4	Chronic Renal Insufficiency 12/2021 - 01/2020
4	Weight Gain 12/2021 - 01/2020
3	Infections 01/2023 - 05/2008
2	Gonorrhea 11/2023 - 05/2008
1	Muscular Atrophy (Muscle Atrophy) 10/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Retinal Diseases 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Fatigue 01/2019
1	Hypoxia (Hypoxemia) 01/2016
1	Dyslipidemias (Dyslipidemia) 07/2015
1	Dehydration (Water Stress) 06/2014
1	Coinfection 01/2007

Drug/Important Bio-Agent (IBA)

5	hydroxide ionIBA 10/2022 - 01/2019
4	Vitamin D FDA LinkGeneric 10/2022 - 01/2019
3	Calcitriol (Calcijex)FDA LinkGeneric 10/2022 - 01/2020
2	LipidsIBA 01/2022 - 01/2016
2	CytokinesIBA 10/2021 - 01/2021
2	Interleukin-1 (Interleukin 1)IBA 10/2021 - 01/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2021 - 01/2021
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 01/2016
2	CarbohydratesIBA 01/2016 - 07/2015
1	Hormones (Hormone)IBA 11/2023
1	Interferon-alpha (Interferon Alfa)IBA 01/2023
1	Butyrates (Butyrate)IBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	CholesterolIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Fibric Acids (Fibrates)IBA 01/2022
1	abacavir (Ziagen)FDA Link 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Calcifediol (Calcidiol)FDA Link 12/2021
1	InterleukinsIBA 10/2021
1	Leptin ReceptorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	LeptinIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	16S Ribosomal RNAIBA 03/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Mitochondrial Uncoupling ProteinsIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Insulin (Novolin)FDA Link 12/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Amino Acids FDA Link 01/2016
1	SolutionsIBA 06/2014
1	SaltsIBA 06/2014
1	Nucleic AcidsIBA 05/2008
1	Cocaine (Cocaine HCl)IBA 01/2007

Therapy/Procedure

3	Therapeutics 11/2023 - 10/2021
1	Art Therapy 01/2022
1	Oral Administration 01/2021
1	Carbohydrate Loading Diet 07/2015